Page last updated: 2024-11-02

pentobarbital and Dizziness

pentobarbital has been researched along with Dizziness in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.

Research Excerpts

ExcerptRelevanceReference
"The objectives of this study were to describe the type and frequency of postdischarge adverse events related to sedation for elective diagnostic imaging in children and to determine if any patient or drug characteristics were associated with such adverse events."1.38Postdischarge adverse events related to sedation for diagnostic imaging in children. ( Chen, X; Kaila, R; Kannikeswaran, N, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaila, R1
Chen, X1
Kannikeswaran, N1

Other Studies

1 other study available for pentobarbital and Dizziness

ArticleYear
Postdischarge adverse events related to sedation for diagnostic imaging in children.
    Pediatric emergency care, 2012, Volume: 28, Issue:8

    Topics: Child; Child, Preschool; Dizziness; Female; Fentanyl; Follow-Up Studies; Humans; Hypnotics and Sedat

2012